Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

De Berardis D.

15 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 9 Safety 8 Receptor Pharmacology 7 Review Article 5 Mechanism of Action 4 Pharmacology 3 Clinical Trial 2 Treatment-Resistant Depression 2 Neuroplasticity 2 Systematic Review 2 Addiction 2 Toxicity 2

Journals

RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia 4 ClinicalTrials.gov 3 Preprints.org 1 Mental Wellness 1 Tobacco induced diseases 1 Progress in neuro-psychopharmacology & biological psychiatry 1 Nature 1 Neuropharmacology 1

Publication history

A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum DisorderPreprints.org · 2026-04-29 The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomesMental Wellness · 2026-04-21 Marketing by online tobacco retailers: An observational cross-sectional study.Tobacco induced diseases · 2026-01-01 Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.Progress in neuro-psychopharmacology & biological psychiatry · 2025-03-20 Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell ModelRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2025-01-01 Psychedelics reopen the social reward learning critical periodNature · 2023-06-13 The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24 Safety and Efficacy of Psilocybin for Body Dysmorphic DisorderClinicalTrials.gov · 2023-03-13 Production and extraction of psilocybin and psilocin from Psilocybe spp. mushroomsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06 Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DADRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06 Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanismsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06 TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT receptor pharmacological tool, or none of the above?Neuropharmacology · 2018-11-01 The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.Frontiers in psychiatry · 2017-01-01 The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)European Psychiatry · 2016-02-29

Author directory